MSWM
ABBV icon

Mader & Shannon Wealth Management’s AbbVie ABBV Stock Holding History

Mader & Shannon Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-47,691
Closed -$3.46M – 26
2017
Q2 		$3.46M Buy
+47,691
New +$3.21M 4.76% 6

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Mader & Shannon Wealth Management's ABBV Position: Q3 2017 in Review

Mader & Shannon Wealth Management sold out of AbbVie (ABBV) in Q3 2017, closing a stake of 47,691 shares — an estimated $3.46M sold.

Mader & Shannon Wealth Management first reported a position in ABBV in Q2 2017 and held it in 1 quarter. The position peaked at $3.46M in Q2 2017. 1,798 funds tracked by Wall St. Rank hold ABBV as of Q3 2017.

  • Mader & Shannon Wealth Management reported no remaining AbbVie position as of Q3 2017 after selling out during the quarter.
  • Mader & Shannon Wealth Management sold 47,691 AbbVie shares in Q3 2017, an estimated $3.46M.
  • Mader & Shannon Wealth Management first reported a position in AbbVie in Q2 2017 and held it in 1 quarter.
  • Mader & Shannon Wealth Management's AbbVie position peaked at $3.46M in Q2 2017.
  • 1,798 funds tracked by Wall St. Rank held AbbVie as of Q3 2017.

Based on Mader & Shannon Wealth Management's 13F filing for Q3 2017, filed 13 Nov 2017.